Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Datametrex AI in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.20.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Datametrex AI. This rating has held steady since June 2020, when it changed from a Buy consensus rating.
Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.